Capillary ultracentrifugation technology in accurate identification of Rh phenotype
10.13303/j.cjbt.issn.1004-549x.2021.03.002
- VernacularTitle:毛细管超速离心技术在Rh表型精准鉴定中的应用
- Author:
Yong DONG
1
;
Shaoqiang ZHANG
1
;
Rong WANG
1
;
Zuzhou HUANG
1
;
Zhen ZHAO
1
;
Songxia YAN
1
;
Shanshan YU
1
;
Ping LI
1
Author Information
1. Department of Blood Transfusion, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
- Publication Type:Journal Article
- Keywords:
capillary ultracentrifugation technology;
Rh phenotype;
targeted blood transfusion
- From:
Chinese Journal of Blood Transfusion
2021;34(3):208-210
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To explore the application of capillary ultracentrifugation technology in accurate identification of Rh phenotype and clinical blood transfusion. 【Methods】 132 samples, presenting mixed field agglutination during Rh phenotyping in our laboratory from May 2019 to February 2020, were separated using capillary ultracentrifugation technology, and the proximal and distal red blood cells were taken for Rh phenotype test, and then blood donors with the same Rh phenotype as the proximal cells were selected for cross matching. 【Results】 132 samples were subjected to capillary ultracentrifugation, and new red blood cells were successfully isolated from the proximal side in 128 (96.97%)cases, and the Rh phenotype was accurately identified, i.e. CcDEe in 47 cases (36.72%), CcDee in 12(9.38%). ), ccDEEin 11 (8.59%), CCDee in 52(40.63%), ccDEe in 5 (3.91%), and ccDee in 1(0.78%). 4 cases of mixed field reaction remained after centrifugation, and all of them had a history of blood transfusion within 2 days. For the 128 patients whose Rh phenotype was accurately identified, blood donors with the same type of Rh phenotype were selected, and 4 patients whose Rh phenotype could not be determined, donors with CCDee phenotype were selected based on the frequency of phenotype distribution and the principle of reducing antigen exposure. The cross-matched blood of all patients were consistent. 【Conclusion】 Capillary ultracentrifugation technology can effectively separate the new red blood cells, improve the accurate identification of Rh phenotype, and provide safety guarantee for clinical targeted blood transfusion.
